Dramatically expands IP portfolio of cannabinoid synthesis related genes and enzymes
Tackles known enzymatic and modification bottlenecks and challenges in biosynthesis
TEL AVIV, Israel , Aug. 11, 2022 /PRNewswire/ -- Xinteza API Ltd., an innovative biosynthesis technology company, announced today that it has expanded its IP portfolio with a breakthrough discovery of a novel, non-cannabis plant-derived production system, which is capable of highly efficient and flawless end-to-end cannabinoid synthesis. The company's IP portfolio is based on a license signed with Yeda, the commercial arm of the Weizmann Institute of Science.
Unlike Cannabis Sativa, which only produces cannabinoids in its female flowering parts, the novel expression system contains cannabinoid enzymatic machinery throughout its entire botanical tissue mass, and thus has the potential to yield a higher active-ingredient-to-biomass ratio than cannabis plants.
"This discovery is a major milestone in the path to uncover and exploit rare and new cannabinoid molecules with potentially novel pharmacological activities," said Prof. Asaph Aharoni , Xinteza's Scientific Co-Founder and Head of the Weizmann Institute of Science Plant Metabolomics Lab and of the Institute's Plant and Environmental Sciences Department. "Moreover, this alternative non-Cannabaceae production system is significantly more amenable than cannabis to genetic engineering and cellular transformation, allowing greater flexibility in a range of biosynthesis enhancement and optimization processes," added Prof. Aharoni.
Biosynthesis technologies have the potential to revolutionize cultivation-and-extraction-based production methods of cannabinoid compounds for CPG and pharma. However, the development of these long-awaited cannabinoid biosynthesis processes has been slowed down and challenged by several enzymatic and genetic modification-related bottlenecks arising from the introduction of cannabis genes into microorganism-based fermentation systems. The discovery of a non-Cannabaceae cannabinoid-producing botanical expression system has the potential to solve and mitigate some of these problems by initiating a novel toolkit of genes and enzymatic machinery. By utilizing this new toolkit, Xinteza aims to design novel pathways for cannabinoid biosynthesis, in order to achieve higher yields and efficiencies, better consistency, purity, and cost effectiveness.
"This revolutionary discovery places Xinteza at the forefront of cannabinoid sourcing and synthesis and is creating excitement in the field" says Alon Gal , CEO of Xinteza API. "The flexibility and efficacy of this extraordinary patent-pending alternative genetic system offers solutions to some of the burning delivery issues currently plaguing our industry. We will continue to advance our research and development of the most innovative and powerful biosynthesis of an array of high-value cannabinoids and to leverage our fast-growing library of genes, enzymes, and novel molecules, while advancing collaborations with leading players in the biosynthesis arena."
Xinteza API Ltd. is engaged in the research and discovery of a wide array of new genes and ultra-novel genetic pathways for the biosynthesis of cannabinoids and psychoactive ingredients, and the development of their bio-production methods. Xinteza holds an exclusive license for both cannabinoids and psychoactives from the Weizmann Institute of Science with research led by Prof. Asaph Aharoni and is diligently building an unprecedented portfolio of dozens of related IP assets and patents.
Founded in 2019 and led by a team of experienced entrepreneurs, Xinteza's strategic partners include industry players such as IM Cannabis (NASDAQ: IMCC)(CSE: IMCC)
Xinteza's goal is to produce a large array of natural lab made minor and modified cannabinoids, and the most sought-after psychoactive ingredients. It focuses on making the production of innovative APIs and AIs for high end CPG and pharma more accessible by implementing its disruptive discoveries of novel genes, genetic pathways, and molecules, and by removing bottlenecks and boosting natural production processes.
Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda currently manages approximately 500 unique patent families and has generated the highest income per researcher compared to any other academic technology transfer operation worldwide. Through the years, Yeda has contributed the commercialization of a number of groundbreaking therapies, such as Copaxone, Rebif, Tookad®, Erbitux®, Vectibix®, Protrazza®, Humira®, and recently the CAR-T cancer therapy Yescarta®.
About the Weizmann Institute of Science
The Weizmann Institute of Science in Israel is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, Weizmann Institute's scientists are advancing research on the human brain, artificial intelligence, computer science and encryption, astrophysics and particle physics, and are tackling diseases such as cancer, while also addressing climate change through environmental, ocean, and plant sciences.
For additional information, visit: https://xinteza.com or visit our official LinkedIn Channel.
Xinteza API Ltd. – Press, MarCom, Investor Relations E: info@xinteza.com
Alon Gal , CEO and co-founder E: alon@xinteza.com
Dr. Zohar Koren, CTO and co-founder E: zohar@xinteza.com
Photo - https://mma.prnewswire.com/media/1876584/Alon_Gal_Xinteza_API_Ltd.jpg Photo - https://mma.prnewswire.com/media/1876676/Prof_Asaph_Aharoni_Weizmann.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/xinteza-unveils-disruptive-non-cannabaceae-source-for-cannabinoid-biosynthesis-in-breakthrough-research-led-by-prof-asaph-aharoni-at-the-weizmann-institute-of-science-301604375.html
While approximately 100,000 to 200,000 people are expected to travel to Florida’s Space Coast to see the Artemis 1 launch, millions of others will watch from home either online or on TV.
NASA Artemis I is unmanned, but it's not flying solo. Here's a list of everything that's flying to the moon on the mega moon rocket when it launches.
NASA/JPL-CaltechIf we ever want to reach the lofty heights of colonizing Mars (paging Elon Musk), then we need to make sure we have plenty of oxygen to keep our astronauts alive. The only problem: there’s not exactly a lot of it on the Red Planet since its atmosphere is mostly carbon dioxide.Luckily, a team of MIT scientists created a device that’s roughly the size of a lunch box and is capable of producing oxygen on Mars—and apparently, it’s been doing so for more than a year now.In a study pub
Saturday's rescheduled Artemis 1 mission is NASA's first step toward returning humans to Earth's Moon.
With the new facility, Collins Aerospace will develop and test new spacesuits to make it safer for astronauts to travel in the coming years, especially as the space industry hopes to send more people to the moon and beyond.
The specimen is likely to provide information about what the dinosaur looked like and its anatomy.
Ground teams at Kennedy Space Center in Florida on Friday began a final full day of launch preparations on the eve of a second attempt to send NASA's giant, next-generation moon rocket on its debut test flight, five days after technical problems foiled an initial try. Mission managers were still "go" for a Saturday afternoon liftoff of the 32-story-tall Space Launch System (SLS) rocket and its Orion space capsule to kick off NASA's moon-to-Mars Artemis program, successor to the Apollo lunar missions a half-century ago, NASA officials said.
A decade ago, Florida’s Space Coast was in the doldrums
The Webb telescope has returned it’s first direct look at an alien world
The majority of fertilized eggs die and are resorbed into the body. ZEISS Microscopy/Flickr, CC BY-SAMany state legislatures are seriously considering human embryos at the earliest stages of development for legal personhood. Total abortion bans that consider humans to have full rights from the moment of conception have created a confusing legal domain that affects a wide range of areas, including assisted reproductive technologies, contraception, essential medical care and parental rights, among
The skeleton of a long-necked Mbiresaurus raathi is believed to be more than 230 million years old.
Yuri Borisov, head of the Roscosmos agency, said mass equipment failures and ageing parts were endangering crew safety on the 24-year-old station. The ISS had been a rare area of cooperation between the United States and Russia even as diplomatic ties worsened. But since Russia invaded Ukraine in February and subjected to a barrage of Western sanctions, it has become more intent on leaving and launching its own space station sometime after 2024.
While Pakistanis count the cost of one of the country's worst recorded floods, heavy rain is hitting southwestern China as the Texas city of Dallas recovers from a 10-inch deluge in a single day last month. Heatwaves are already more frequent and intense worldwide, increasing evaporation from both the land and the ocean.
WASHINGTON (Reuters) -SpaceX will launch five more astronaut missions to the International Space Station for NASA at the end of the decade under a $1.4 billion contract order, the U.S. space agency said Wednesday, taking the company's total contracted missions for its Crew Dragon astronaut capsule to 14. The latest boost to SpaceX's NASA contract is part of the agency's effort to ensure a steady run of astronaut flights to the space station as Boeing, the other company with a similar crew transportation contract, has struggled to complete development of its Starliner space capsule.
Scientists unearth ancient tomb in Peru
NASA is preparing for its second Artemis I launch attempt, set for Saturday afternoon.
NASA, NOAA Invite Media to Polar Orbiting Weather Satellite LaunchPR NewswireWASHINGTON, Sept. 1, 2022 /PRNewswire/ -- NASA is accepting media requests for launch coverage of the National Oceanic and Atmospheric Administration (NOAA) Joint Polar Satellite System-2 (JPSS-2) satellite.
The auto maker reported a fourfold surge in electric-vehicle sales amid strong interest in its all-electric F-150 Lightning truck.
The U.S. dollar is on a tear, hitting historic highs against major rivals. Here's how that could add to market volatility.
Style Box ETF report for IWX